
|Articles|June 1, 2018
- Pharmaceutical Executive-06-01-2018
- Volume 38
- Issue 6
Pharmaceutical Executive, June 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
US Maps Strategy to Reform Drug Pricingover 7 years ago
C-Suite Personality: Fit for Future?almost 8 years ago
Insights for the Winalmost 8 years ago
Leveraging Lab Data in Advent of Personalized Marketingalmost 8 years ago
Asembia 2018: User-Friendly Urgencyalmost 8 years ago
Piecing Together the Pricing Puzzle: The Midterm Electionsalmost 8 years ago
Pharm Exec's Top 50 Companies 2018Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Agentic AI and the Future of Commercial Excellence in Life Sciences
3
FDA Expands Approval for Arexvy for Adult Patients Aged 18-49
4
Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals
5




